Search

Search Constraints

You searched for: Author/Creator Barohn, Richard

Search Results

1. Randomized phase 2 trial of NP001–a novel immune regulator: Safety and early efficacy in ALS. Issue 3 (June 2015)

2. Review process for IVIg treatment: Lessons learned from INSIGHTS neuropathy study. Issue 5 (October 2018)

4. Corrigendum to "Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients". (4th December 2019)

5. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial. Issue 3 (March 2019)

6. Preface: promoting research in PLS: current knowledge and future challenges. (2nd November 2020)

7. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Issue 7 (July 2021)

8. Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre‐specified and post hoc analyses. Issue 1 (3rd June 2022)

9. Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis. (12th April 2016)

10. Frontiers: Integration of a Research Participant Registry with Medical Clinic Registration and Electronic Health Records. Issue 5 (3rd August 2015)